Every October, breast cancer coverage leans on a familiar vocabulary: fighter, warrior, survivor, inspiring, strong. While the language is well-meaning many patients view it as incomplete.

Miranda McKeon felt a lump the summer after her freshman year at the University of Southern California. She was 19. The diagnosis was stage 3 invasive ductal carcinoma, with no family history of breast cancer. Genetic testing later identified a CHEK2 mutation, a variant associated with roughly double the average lifetime risk of breast cancer. Over eight months, she froze her eggs, completed eight rounds of chemotherapy, underwent a double mastectomy and revision, and finished 25 rounds of radiation. She was declared cancer-free at 20. This February, she will reach five years.

McKeon, now 24, has built a large public platform around her experience with breast cancer. I spoke with McKeon about her journey facing cancer and what hardship she truly endured.

The Problem With “You Are So Strong”

Of everything people said to McKeon during treatment, few phrases grated like comments about her strength or ability to push forward. What she wants people to understand is not how strong she was, but how much the word “strong” obscures. Well-meant encouragement can slide into what psychologists call toxic positivity: the pressure to stay upbeat that leaves little room for fear, grief or pain.

The pressure patients with cancer feel is measurable. In a 2018 survey commissioned by Macmillan Cancer Support, a leading U.K. cancer charity, 28% of people with cancer said they felt guilty when they could not stay positive about their disease. A quarter had not shared their thoughts about death with anyone because of pressure to see themselves as a “fighter.” The charity warned that framing cancer as a battle can leave patients feeling guilty for simply admitting fear.

“I didn’t feel strong because of my circumstances,” she said. “Anyone would go through it, because you would have to.”

Treatment, she told me, did not feel like a choice. And that is the flaw in the compliment. Undergoing treatment is not a test of willpower when it is the only option on the table. Calling it strength implies otherwise, as if a weaker person might have opted out. It also sets a standard of endurance that patients may feel obligated to meet, even on their hardest days. For McKeon, the praise did not lift her up. “It almost felt like an extra weight,” she said.

The Pain That Rarely Makes the Story

Media coverage on breast cancer survivor narratives tend to skip past the procedures themselves. McKeon does not.

Before her diagnosis, she underwent several biopsies under local anesthesia. During one, the needle struck a nerve. “I have never been in more pain in my life,” she said. Her body went into shock.

More than 1 million women in the United States undergo a breast biopsy each year, and while most tolerate it well, not all are so lucky. In a Duke University study of 136 women undergoing image-guided breast biopsies, nearly 12% reported moderate to severe pain , and younger age was among the strongest predictors. McKeon was 19.

She believes patients deserve a frank conversation about pain control beforehand, including whether sedation is an option. The research supports her. Patients who anticipated more pain tended to experience more of it, and the study’s authors recommended clearer communication before the procedure. When pain is not anticipated, it is too often not treated.

Fertility, Menopause and Conversations No One Prepares You For

Chemotherapy can damage ovarian function. Depending on age and regimen, studies estimate that between 21% and 71% of young women stop menstruating after multi-agent chemotherapy. McKeon froze eggs before starting treatment, but the retrieval yielded fewer than her team had hoped, and there was no time to try again. She still does not know whether she will be able to conceive.

When asked whether any part of her cancer experience had not made her stronger, this was the first thing she named. She does not see the uncertainty as a lesson or a source of growth. It is a weight she carries into every conversation about her future.

“I still have a whole road ahead of figuring out what my fertility looks like,” she said. “I don’t think I’m better off for it.”

Treatment also left her in medically induced menopause in her early twenties. Vaginal dryness and painful sex are common consequences of estrogen loss, and they are often treatable, yet McKeon found almost no guidance aimed at someone her age. Her age-matched friends were not facing it. Online, the rare useful source was written for women decades older.

“No one’s catering their content towards me,” she said. “I’m like a nonexistent population.”

And yet, she is far from alone. In the WISH-BREAST survey of 1,775 breast cancer survivors, nearly 90% reported moderate to major changes in their sexual well-being . Yet 73% said they received no sexual health information from their oncology team, and 80% turned to the internet instead.

McKeon also had to unlearn the shame many women are taught to feel about raising sexual health with their doctors. In one University of Chicago study, 42% of breast and gynecologic cancer survivors wanted medical help with sexual concerns , but only 7% asked for it. Clinicians have the best opportunity to close that gap by asking and educating first.

When Cancer-Free Isn’t Fear-Free

Nearly five years out, fear of recurrence remains constant, in a changed form. Early on, McKeon’s fears centered on losing her hair again. Then on putting a partner through treatment. Now it reaches toward having children and, once born, the possibility of leaving them behind.

Her experience is common, particularly among young survivors. Research consistently finds that fear of recurrence is more intense in younger women. In a study that followed 965 women diagnosed with breast cancer at age 40 or younger, about one-third had severe fear of recurrence that did not improve, or worsened, over the five years after diagnosis.

A backache can briefly become a tumor in her mind. McKeon has learned to interrupt the spiral, helped by her oncologist’s distinction: concerning pain tends to persist, while ordinary pain comes and goes.

She also names a loss that is harder to measure. Confronting her mortality so young, she said, made her grow up quickly and took a kind of innocence she sees others keep for life. There is a distinct before and after, and she misses the before.

As an emergency physician, I see this often in patients facing cancer. Those who have lived with such heightened uncertainty and fear tend to carry a deeper, more holistic view of the world and how fragile it is.

The Weight of Turning Pain Into Purpose

McKeon feels a responsibility to keep speaking, particularly as, she points out, more young women are being diagnosed. That pressure peaks every October, when invitations multiply and declining one feels like letting the community down.

She is not alone in feeling that pull. In one qualitative study of young adults who had recently finished cancer treatment, participants described feeling isolated within the cancer community, yet expressed a strong desire to share what they had learned and a responsibility to help those newly diagnosed. But that kind of visibility has a cost. A separate study of 45 young adults with cancer found that while peer support on social media helped them feel validated , it could also become an emotional burden.

“I need to be a human too,” she said, “and take care of myself first.”

She also resists being defined by the disease. Her life includes fashion, philanthropy and ambitions well beyond cancer advocacy. This month she joined the brand Park as its philanthropic marketing advisor, pressing companies to consult survivors before launching pink-themed campaigns and inadvertently borrowing the cause without the community.

McKeon has not rejected the idea of strength as much as she has relocated it. In her view, strength is not something handed to patients at diagnosis. It is built through how they choose to reflect, grow, connect, and advocate for change.

For families, friends and clinicians, the takeaway is simple. Ask about the pain, the fertility questions, the sexual health changes and the fear that lingers long after treatment ends. Survivors are carrying all of it, whether or not we correctly name it.